跳至主要内容
临床试验/NCT04957849
NCT04957849尚未招募不适用

The Neuroendoscopic, Trans-occipital Approach Evacuation of Acute Hypertensive Cerebral Hemmorrhage Combined Low-drainage Surgery: a Multi-center Clinical Trial

Shanghai Changzheng Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,000
试验地点
1
主要终点
Clinical remission rate

研究概览

简要总结

The Neuroendoscopic, Trans-occipital Approach Evacuation of Acute Hypertensive Cerebral Hemmorrhage Combined Low-drainage Surgery: a Multi-center Clinical Trial

详细描述

To evaluate the effect of different surgical approaches on the prognosis of patients with hypertensive intracerebral hemorrhage, hypertensive patients who met the diagnostic criteria of American guidelines for the treatment of adult spontaneous intracerebral hemorrhage (2015) were selected. The time from onset to admission was less than 8 hours. Blood routine examination, liver and kidney function, coagulation system, infectious diseases and other examinations were performed before operation, with emergency surgical indications, They were divided into two groups: transfrontal keyhole approach and transoccipital keyhole approach. Emergency endoscopic hematoma removal was performed. The patients were systematically evaluated and followed up at 1 week, 1 month, 3 months, 6 months and 12 months after operation to observe the improvement of consciousness, GCS score, postoperative rebleeding (appearance, bleeding volume, location, broken into ventricle, etc.), The prognosis was evaluated by ADL score, GCS score, gos score, modified Rankin scale, Mrs scale and ICH Score (GCS, hematoma volume, intraventricular hemorrhage, infratentorial source, patient age, etc.).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed patients with spontaneous cerebral hemorrhage in the basal ganglia (in line with the diagnostic criteria of the American Adult Spontaneous Cerebral Hemorrhage Treatment Guidelines (2015)).
  • Head CT showed; hematoma volume ≥ 30ml, intraventricular hemorrhage is not counted as hemorrhage volume.
  • Time from onset to hospital admission ≤8h.
  • The age of the patient is 15-75 years old.
  • Glasgow Coma Score (GCS)> 5 points.
  • The patient/family knows and signs the informed consent form.
  • Have a clear history of hypertension in the past.

排除标准

  • Bleeding caused by aneurysm, vascular malformation or tumor stroke.
  • Combined with a history of head injury or trauma.
  • There is more blood in the skull.
  • Past mental disorders or neurological dysfunction.
  • A history of procoagulant dysfunction or anticoagulant drugs.
  • Patients with complications such as liver and kidney dysfunction.
  • Those with poor compliance.
  • Pregnant patients.
  • With massive hemorrhage of the ventricle (the area of the hematoma in the CT side is larger than 1/2 of the transverse section), hemorrhage in the third and fourth ventricles with enlarged ventricles.
  • With late-stage cerebral herniation (bilateral dilated pupils, central respiratory and circulatory failure).
  • Severe cardiovascular and cerebrovascular diseases: such as myocardial infarction, cerebral infarction, coronary heart disease, myocarditis, malignant arrhythmia, etc.
  • Participate in other clinical research 3 months before enrollment.
  • The doctor in charge believes that the study plan cannot be followed.
  • Those who are or plan to become pregnant or breastfeeding.
  • Those who are known to be allergic to test drugs or related products.

结局指标

主要结局

Clinical remission rate

时间窗: 1 month postoperation

The evaluation criteria of complete remission: more than 85% of intracranial hematoma was cleared, mild brain edema, and the postoperative hospital stay was less than 2 weeks. The evaluation criteria of partial remission: the clearance rate of intracranial hematoma was 60% - 85%, the postoperative brain edema was obvious, and the postoperative hospital stay was less than 4 weeks.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hou Lijun

Professor

Shanghai Changzheng Hospital

研究点 (1)

Loading locations...

相似试验